Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764276
Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Gynecologic SurgeryNational Taiwan University HospitalRecruitingNot Applicable
NCT07764276Recruiting
Not Applicable
Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Gynecologic Surger...National Taiwan Universit...
NCT07763652
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid TumorsBaili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07763652Not Yet Recruiting
Phase 1
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointes...Baili-Bio (Chengdu) Pharm...
NCT07762599
Silver Nanoparticle-Reinforced Double Antibiotic Paste in Symptomatic Apical Periodontitis: A Randomized Controlled TrialAll India Institute of Medical SciencesNot Yet RecruitingNot Applicable
NCT07762599Not Yet Recruiting
Not Applicable
Silver Nanoparticle-Reinforced Double Antibiotic Paste in Symptomatic Apical Per...All India Institute of Me...
NCT07762508
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low-Performance or High-Comorbidity AML Patients in CR1The First Affiliated Hospital of Soochow UniversityNot Yet RecruitingNot Applicable
NCT07762508Not Yet Recruiting
Not Applicable
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low...The First Affiliated Hosp...
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762885
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryFudan UniversityRecruitingPhase 3
NCT07762885Recruiting
Phase 3
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma...Fudan University
NCT07764159
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of WarsawNot Yet RecruitingNot Applicable
NCT07764159Not Yet Recruiting
Not Applicable
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of War...
NCT07762677
This Prospective Observational Study Aims to Evaluate the Capability of Ultra-high-resolution Photon-counting CT Angiography (UHR PCD-CTA) for Noninvasive Evaluation of Intracranial Venous Sinus Stents. The Study Will Compare Image Quality, Stent Visualization, Metal-related Artifacts, and DiagnostiXin LouRecruiting
NCT07762677Recruiting
—
This Prospective Observational Study Aims to Evaluate the Capability of Ultra-hi...Xin Lou
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763717
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIALAlma Mater Europaea - SloveniaNot Yet RecruitingNot Applicable
NCT07763717Not Yet Recruiting
Not Applicable
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE...Alma Mater Europaea - Slo...
NCT07763743
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy With Vacuum-Assisted Access SheathAin Shams UniversityRecruitingNot Applicable
NCT07763743Recruiting
Not Applicable
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ure...Ain Shams University
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan UniversityRecruitingPhase 2
NCT07762924Recruiting
Phase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Fol...Fudan University
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07763002
Acute Effects of Functional Inspiratory Muscle Training in Elite Male Volleyball PlayersGazi UniversityRecruitingNot Applicable
NCT07763002Recruiting
Not Applicable
Acute Effects of Functional Inspiratory Muscle Training in Elite Male Volleyball...Gazi University
NCT07762950
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisChanghai HospitalNot Yet Recruiting
NCT07762950Not Yet Recruiting
—
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancre...Changhai Hospital
NCT07762690
Mechanism-Based Cervical Rehabilitation for Chronic MigraineBeni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07762690Not Yet Recruiting
Not Applicable
Mechanism-Based Cervical Rehabilitation for Chronic MigraineBeni-Suef University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting7 (35%)
Completed2 (10%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 12 (10%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)